171 related articles for article (PubMed ID: 17320297)
1. Insulin-like growth factor type I biology and targeting in malignant gliomas.
Trojan J; Cloix JF; Ardourel MY; Chatel M; Anthony DD
Neuroscience; 2007 Mar; 145(3):795-811. PubMed ID: 17320297
[TBL] [Abstract][Full Text] [Related]
2. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
4. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
Sonabend AM; Dana K; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
[TBL] [Abstract][Full Text] [Related]
5. IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.
Trojan LA; Kopinski P; Wei MX; Ly A; Glogowska A; Czarny J; Shevelev A; Przewlocki R; Henin D; Trojan J
Acta Biochim Pol; 2002; 49(4):979-90. PubMed ID: 12545204
[TBL] [Abstract][Full Text] [Related]
6. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways.
Newton HB
Expert Rev Anticancer Ther; 2003 Oct; 3(5):595-614. PubMed ID: 14599084
[TBL] [Abstract][Full Text] [Related]
7. IGF-I triple helix gene therapy of rat and human gliomas.
Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
[TBL] [Abstract][Full Text] [Related]
9. Molecularly targeted therapy for malignant glioma.
Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
[TBL] [Abstract][Full Text] [Related]
10. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
12. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
13. [The biology of gliomas: growth factors and oncogene expression. A current review].
Westphal M; Herrmann HD
Fortschr Neurol Psychiatr; 1988 Feb; 56(2):59-66. PubMed ID: 3283009
[TBL] [Abstract][Full Text] [Related]
14. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for malignant glioma.
Lesniak MS
Expert Rev Neurother; 2006 Apr; 6(4):479-88. PubMed ID: 16623647
[TBL] [Abstract][Full Text] [Related]
16. Editorial review: targets for glioma treatment: from bench to bedside.
Sanson M
Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046
[TBL] [Abstract][Full Text] [Related]
17. Development of novel targeted therapies in the treatment of malignant glioma.
Rich JN; Bigner DD
Nat Rev Drug Discov; 2004 May; 3(5):430-46. PubMed ID: 15136790
[No Abstract] [Full Text] [Related]
18. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
Argyriou AA; Giannopoulou E; Kalofonos HP
Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
[TBL] [Abstract][Full Text] [Related]
19. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
20. A multivariate analysis of patients with brain tumors treated with ATN-RNA.
Wyszko E; Rolle K; Nowak S; Zukiel R; Nowak M; Piestrzeniewicz R; Gawrońska I; Barciszewska MZ; Barciszewski J
Acta Pol Pharm; 2008; 65(6):677-84. PubMed ID: 19172848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
